MDT - Spark Newswire

1 minute read

Medtronic Issues Voluntary Recall For TurboHawk Plus Directional Atherectomy System

February 7, 1:20 PM

Medtronic Plc (NYSE: MDT) has initiated a voluntary recall to customers related to the risk associated with tip damage caused by guidewire prolapse in its 6 French (6Fr) TurboHawk Plus Directional Atherectomy System.

MDT

4 minute read

FDA
News

Medtronic Continuous Glucose Monitoring To Be Reimbursed For Eligible Alberta Youth Living With Diabetes

By Benzinga Newsdesk

February 3, 5:35 PM

Medtronic continuous glucose monitoring to be reimbursed for eligible Alberta youth living with diabetes New government program enables access to integrated hybrid closed loop technology for 18 and under BRAMPTON,

MDT

1 minute read

Needham Maintains Buy on Medtronic, Lowers Price Target to $128

By Benzinga Newsdesk

January 25, 5:37 AM

Needham analyst Mike Matson maintains Medtronic (NYSE:MDT) with a Buy and lowers the price target from $131 to $128.

MDT

3 minute read

FDA
News

Medtronic Announces FDA Approval Of Spinal Cord Stimulation Therapy For Treating Chronic Pain Resulting From Diabetic Peripheral Neuropathy

By Benzinga Newsdesk

January 24, 12:01 PM

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it has received U.S. Food and Drug Administration approval of its Intellis™ rechargeable neurostimulator and Vanta™

MDT

2 minute read

Medtronic Recalls HawkOne Atherectomy System Due To Tip Damage Risk

By Vandana Singh

January 21, 11:32 AM

Medtronic Inc (NYSE: MDT) is recalling HawkOne Directional Atherectomy System due to the risk of the guidewire within the

MDT

1 minute read

10 Biggest Price Target Changes For Friday

By Lisa Levin

January 21, 8:35 AM

Barclays cut Netflix, Inc. (NASDAQ: NFLX) price target from $675 to $425. Netflix shares fell 19.6% to $408.58 in pre-market trading.

CMG

1 minute read

SVB Leerink Maintains Market Perform on Medtronic, Lowers Price Target to $115

By Benzinga Newsdesk

January 21, 7:22 AM

SVB Leerink analyst Danielle Antalffy maintains Medtronic (NYSE:MDT) with a Market Perform and lowers the price target from $138 to $115.

MDT

1 minute read

Citigroup Maintains Buy on Medtronic, Lowers Price Target to $129

By Benzinga Newsdesk

January 19, 8:34 AM

Citigroup maintains Medtronic (NYSE:MDT) with a Buy and lowers the price target from $130 to $129.

MDT

1 minute read

Medtronic’s Spinal Cord Stimulation Therapy Shows Meaningful Pain Relief

By Vandana Singh

January 14, 2:10 PM

Medtronic plc (NYSE: MDT)

MDT

2 minute read

FDA
News

Medtronic Announces Results Showing Meaningful Pain Relief Using DTM Spinal Cord Stimulation Endurance Therapy

By Benzinga Newsdesk

January 14, 1:01 PM

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced three-month results from an on-label, prospective, multi-center study1 showing meaningful pain relief using DTM™ SCS

MDT

Feed Symbols: MDT